Jayanth Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 9.90 Cr
as on 29-06-2024
- Paid Up Capital ₹ 8.04 Cr
as on 29-06-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.35 Cr
as on 29-06-2024
- Satisfied Charges ₹ 20.05 Cr
as on 29-06-2024
- Revenue -18.61%
(FY 2020)
- Profit -78.97%
(FY 2020)
- Ebitda -11.74%
(FY 2020)
- Net Worth 227.70%
(FY 2020)
- Total Assets 6.32%
(FY 2020)
About Jayanth Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.90 Cr and a paid-up capital of Rs 8.04 Cr.
The company currently has active open charges totaling ₹1.35 Cr. The company has closed loans amounting to ₹20.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Baireddy Jaya and Koti Baireddy serve as directors at the Company.
- CIN/LLPIN
U24231TG2011PTC073241
- Company No.
073241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jayanth Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baireddy Jaya  | Director | 14-Mar-2011 | Current |
| Koti Baireddy | Director | 27-Apr-2019 | Current |
Financial Performance of Jayanth Life Sciences.
Jayanth Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 78.97% decrease in profit. The company's net worth Soared by an impressive increase of 227.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jayanth Life Sciences?
In 2019, Jayanth Life Sciences had a promoter holding of 77.27% and a public holding of 22.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
J.K. Chemlabs Private LimitedActive 13 years 9 monthsBaireddy Jaya and Koti Baireddy are mutual person
- Jayanth Pharmaceuticals Private LimitedActive 22 years 10 months
Baireddy Jaya and Koti Baireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 20 Jun 2023 | ₹3.39 M | Open |
Indian Bank Creation Date: 28 Apr 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 10 Aug 2022 | ₹1.20 M | Open |
How Many Employees Work at Jayanth Life Sciences?
Jayanth Life Sciences has a workforce of 56 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jayanth Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jayanth Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
